Epithelial cell adhesion molecule (EpCAM) regulates HGFR signaling to promote colon cancer progression and metastasis

Epithelial cell adhesion molecule (EpCAM) regulates HGFR signaling to promote colon cancer progression and metastasis

Abstract Background Epithelial cell adhesion molecule (EpCAM) is known to highly expression and promotes cancer progression in many cancer types, including colorectal cancer. While metastasis is one of the main causes of cancer treatment failure, the involvement of EpCAM signaling in metastatic proc...

Full description

Bibliographic Details
Main Authors:	Chi-Chiu Lee, Chia-Jui Yu, Sushree Shankar Panda, Kai-Chi Chen, Kang-Hao Liang, Wan-Chen Huang, Yu-Shiuan Wang, Pei-Chin Ho, Han-Chung Wu
Format:	Article
Language:	English
Published:	BMC 2023-08-01
Series:	Journal of Translational Medicine
Subjects:	EpCAM EpEX HGFR Cancer progression Epithelial-to-mesenchymal transition Invasion
Online Access:	https://doi.org/10.1186/s12967-023-04390-2

Similar Items

Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE
by: Tomaž Žagar, et al.
Published: (2021-05-01)

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs
by: Joanna Macdonald, et al.
Published: (2018-01-01)

Evolution of Thyroglobulin Loop Kinetics in EpCAM
by: Serena H. Chen, et al.
Published: (2021-09-01)

EpCAM as a novel therapeutic target for hepatocellular carcinoma
by: Vasanthakumar S, et al.
Published: (2017-07-01)

Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2
by: Ya-feng Lv, et al.
Published: (2023-12-01)

Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications
by: Guanjie Li, et al.
Published: (2022-06-01)

EpCAM (CD326) Regulates Intestinal Epithelial Integrity and Stem Cells via Rho-Associated Kinase
by: Takeshi Ouchi, et al.
Published: (2021-01-01)

Dynamic Expression of EpCAM in Primary and Metastatic Lung Cancer Is Controlled by Both Genetic and Epigenetic Mechanisms
by: Yeting Cui, et al.
Published: (2022-08-01)

Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
by: Anzhelika Vorobyeva, et al.
Published: (2020-05-01)

Amelioration of Congenital Tufting Enteropathy in EpCAM (TROP1)-Deficient Mice via Heterotopic Expression of TROP2 in Intestinal Epithelial Cells
by: Gaku Nakato, et al.
Published: (2020-08-01)

Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
by: Tianqi Xu, et al.
Published: (2021-08-01)

Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1
by: Anzhelika Vorobyeva, et al.
Published: (2020-10-01)

A meta-analysis and The Cancer Genome Atlas data of prostate cancer risk and prognosis using epithelial cell adhesion molecule (EpCAM) expression
by: Yu Hu, et al.
Published: (2019-07-01)

Current View on EpCAM Structural Biology
by: Aljaž Gaber, et al.
Published: (2020-05-01)

Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins
by: Chuan-Jin Wu, et al.
Published: (2020-04-01)

A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian Cancer
by: Emily Maria Ploeg, et al.
Published: (2023-07-01)

mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth
by: Vita Golubovskaya, et al.
Published: (2023-05-01)

Targeted EpCAM-binding for the development of potent and effective anticancer proteins
by: Zhao Liu, et al.
Published: (2023-05-01)

Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Salivary Gland Cancer: Correlation with the Biological Behavior
by: Ioanna Kalaitsidou, et al.
Published: (2023-08-01)

Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition
by: Taylor C. Brown, et al.
Published: (2021-06-01)

An Intrabody against B-Cell Receptor-Associated Protein 31 (BAP31) Suppresses the Glycosylation of the Epithelial Cell-Adhesion Molecule (EpCAM) via Affecting the Formation of the Sec61-Translocon-Associated Protein (TRAP) Complex
by: Tianyi Wang, et al.
Published: (2023-09-01)

Comprehensive analysis reveals dual biological function roles of EpCAM in kidney renal clear cell carcinoma
by: Mei Chen, et al.
Published: (2024-01-01)

Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors
by: Min Wei, et al.
Published: (2022-11-01)

Anti-EpCAM Functionalized I-131 Radiolabeled Biomimetic Nanocarrier Sodium/Iodide-Symporter-Mediated Breast-Cancer Treatment
by: Suphalak Khamruang Marshall, et al.
Published: (2022-06-01)

Targeting EpCAM by a Bispecific Trifunctional Antibody Exerts Profound Cytotoxic Efficacy in Germ Cell Tumor Cell Lines
by: Stefan Schönberger, et al.
Published: (2020-05-01)

Targeting liver cancer stem cell through EpCAM therapy targeted with chemotherapy endorse enhanced progression in hepatocellular carcinoma
by: Vasanthakumar Sekar, et al.
Published: (2023-06-01)

Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin–Toxin Fusion in a Pancreatic Cancer Xenograft Model
by: Tianqi Xu, et al.
Published: (2023-02-01)

Leukocyte-Derived Extracellular Vesicles in Blood with and without EpCAM Enrichment
by: Afroditi Nanou, et al.
Published: (2019-08-01)

The Detection of Immunity against WT1 and SMAD4<sup>P130L</sup> of EpCAM<sup>+</sup> Cancer Cells in Malignant Pleural Effusion
by: Terutsugu Koya, et al.
Published: (2022-10-01)

Comparison of circulating tumor cell (CTC) detection rates with epithelial cell adhesion molecule (EpCAM) and cell surface vimentin (CSV) antibodies in different solid tumors: a retrospective study
by: Yang Gao, et al.
Published: (2021-03-01)

Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients
by: Manar AbdelMageed, et al.
Published: (2021-12-01)

Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer
by: Elham Kalantari, et al.
Published: (2022-01-01)

Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
by: Sergey M. Deyev, et al.
Published: (2021-07-01)

A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG<sub>2a</sub>-f) Exerts Antitumor Activity in Xenograft Model
by: Teizo Asano, et al.
Published: (2022-11-01)

Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma
by: Mohammad Mashreghi, et al.
Published: (2020-05-01)

A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy
by: Gerhard Frey, et al.
Published: (2024-12-01)

EpCAM- and EGFR-Specific Antibody Drug Conjugates for Triple-Negative Breast Cancer Treatment
by: Chaoyu Zhang, et al.
Published: (2022-05-01)

Photo-functionalized TiO2 film for facile immobilization of EpCAM antibodies and efficient enrichment of circulating tumor cells
by: Huan Deng, et al.
Published: (2023-02-01)

A Novel Function for KLF4 in Modulating the De-Differentiation of EpCAM<sup>−</sup>/CD133<sup>−</sup> nonStem Cells into EpCAM<sup>+</sup>/CD133<sup>+</sup> Liver Cancer Stem Cells in HCC Cell Line HuH7
by: Zeynep Firtina Karagonlar, et al.
Published: (2020-05-01)

CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy
by: Daan Linders, et al.
Published: (2021-03-01)